(MRNA) Moderna stock forecast for 2024, 2025, 2026-2030 and Beyond

2024.05.17 2024.05.20
(MRNA) Moderna stock forecast for 2024, 2025, 2026-2030 and Beyond

Jana Kanehttps://www.litefinance.org/blog/authors/jana-kane/

To make a forecast for Moderna shares and have an idea of what investors can expect from MRNA, experts analyze market trends and financial indicators.  

Is Moderna’s share price expected to rise, or will the rate decline? Analysts are overall positive and expect Moderna’s stock to grow in value. In this article, you will explore a comprehensive analysis of expert forecasts, delving into the factors influencing Moderna’s stock rate.

Highlights and Key Points: Moderna Stock Forecast 2024-2030

• Today, on 20.05.2024, #MRNA stock price is $132.88.
• 2024 Projections: LongForecast predicts a steady rise, with prices ranging from $118 – $201, while WalletInvestor forecasts significant fluctuations.
• 2025 Expectations: Longforecast indicates a solid upward trend, with prices potentially reaching $299. WalletInvestor anticipates prices between $83.747 and $107.992.
• Long-Term Outlook (2026-2030): Continued growth is anticipated, with WalletInvestor projecting an increase by late 2028.
• Influencing Factors: Moderna’s pioneering work in mRNA technology and expanding pharmaceutical portfolio drive optimistic forecasts.
• Impactful Factors: Earnings estimates, revenue growth, financial performance, valuation, and Zacks Rank significantly influence Moderna’s stock price.

Moderna Stock Price Today Coming Days and Week

When forecasting Moderna’s stock price in the near term, it’s essential to focus on several key factors. First, watch for updates on vaccine trials and approvals, which can cause significant price movements. Regulatory news and government contracts are also critical, especially concerning new vaccines development. Economic conditions impacting biotech investments, including interest rates and funding for healthcare innovations, should be monitored. Additionally, use technical analysis to track trading volumes and price trends to gauge investor sentiment. These combined insights will provide a clearer picture of potential movements in Moderna’s stock price.

Analysts’ Moderna Stock Projections for 2024

Let’s take a look at expert forecasts for the MRNA rate in 2024.

LongForecast

Price range for 2024: $132 – $211 (as of May 17, 2024).

LongForecast presents an optimistic outlook for Moderna’s stock in 2024, anticipating a bullish trend. The analysis predicts a steady ascent, culminating in December. This gradual increase suggests growing investor confidence in Moderna, likely driven by favorable market conditions or positive business developments. The forecast also points to expected monthly fluctuations, indicative of market volatility, yet maintains an overarching positive trajectory.

WalletInvestor

Price range for 2024: $118.739 – $129.924 (as of May 17, 2024).

WalletInvestor’s forecast paints a picture of a volatile market. The price will significantly grow by mid-year but decline by year-end. This fluctuation suggests a market sensitive to varying factors, including industry developments or broader economic conditions.

Moderna (MRNA) Stock Technical Analysis

If we look at Moderna’s 5-year price chart, we will see that the price movements can be divided into two periods: 

• 1st period: a global bullish trend up to mid-2021;
• 2nd period: a continued decline after mid-2021.

Trends are clearly identified on a weekly time frame, so smaller time frames, such as daily or 4-hour, are perfectly suitable for technical analysis. The presence of an uptrend or a downtrend on smaller time frames will make analysis easier and allow us to make better-informed trading decisions.

To perform this analysis, we will use standard indicators: trendlines, Fibonacci levels, and moving averages. The following indicators will also be helpful:

• Bollinger Bands. They show the current price deviations from the moving average;
• RSI. It determines the strength of a trend and the probability of its reversal;
• ADX. It measures the strength of a trend over a specific period;
• CCI. It measures an asset’s price deviation from its average value over a certain period.

#MRNA Stock Forecast For Next Three Months

Let’s make a forecast for Moderna stock for the next three months, marking out the last segment of the daily chart.

The chart shows a large bearish impulse [1]-[2]-[3]-[4]-[5] forming. Subwaves [1], [2], and [3] are fully completed, and corrective wave [4] is unfolding.

This wave will presumably form as a bullish triple zigzag (W)-(X)-(Y)-(X)-(Z). The first three parts of this pattern are simple A-B-C zigzags. Not long ago, the price started declining in correction [4], a part of the second linking wave (X).

Wave (X) may end at around 94.68, where its size will be 76.4% of wave (Y) as per Fibonacci ratios. Then, we may see an upward movement in the final zigzag (Z) to 128.54.

Thus, the price may reach 101.61 in a descending wave (X) in about a month (as indicated by the first vertical line). Then, wave (X) will be fully complete, and the market will grow in (Z). By the end of the second month, the price may reach 106.48 (marked by the second vertical line). By the end of the third month, wave (Z) may end forming, and the price will reach the maximum of (Y), i.e., 128.54.

Long-Term Moderna Technical Analysis for 2024

For technical analysis of Moderna shares in 2024, we’ll analyze the largest timeframes. First, let’s parse the weekly chart.

A global bullish zigzag (A)-(B)-(C) marked with blue letters forms on the weekly timeframe. The impulse wave (A) was fully completed in the middle of 2021, and then a long-term gradual decline in the corrective wave (B) started.

Wave (B) is close to completion as a simple downward zigzag A-B-C. We see the final part of the impulse wave C developing. This wave includes sub-waves [1]-[2]-[3]-[4]-[5]. The correction [4] is ending, and the price is expected to decline in the impulse wave [5].

To make a better-informed forecast, we’ll explore the daily timeframe.

The corrective wave [4] is nearing completion and is expected to reach 128.54. Then, the price may decline in the impulse [5] to the minimum of [3] at 63.07.

The completion of wave [5] will indicate that the correction (B) has finished developing. Then, a major bullish trend in impulse wave (C) is expected, and the price may reach 275.00 by the end of 2024.

Long-term trading plan for Moderna Inc. (#MRNA)

Now, we can make a detailed trading plan.

• From now on, short positions can be opened with a target of 94.68 – a decline in the linking wave (X).
• Long positions can be opened from 94.68 at the end of June, with a target of 128.54 – growth in the final wave (Z), which is a part of the correction [4].
• Short positions can be opened from 128.54, with a target of 63.07 – a decline in impulse [5].
• Long positions can be opened from 63.07, i.e., from around October until the end of 2024, with a target of 275.00 – growth in a new major bullish impulse (C).

All subwaves can be seen in the charts above

Moderna Stock Forecast for 2025

Let’s take a look at expert forecasts for the MRNA rate in 2025.

LongForecast

Price Range for 2025: $102.16–$191.96 (as for February 22, 2024)

LongForecast predicts a consistent bullish trend for Moderna’s stock in 2025. The stock will be priced at $195 in January, gradually increasing each month to reach $286 by December. This consistent rise reflects investor confidence and optimism about Moderna’s market performance and potential in the pharmaceutical industry.

WalletInvestor

Price range for 2025: $83.747 – $107.992 (as of May 17, 2024).

Walletinvestor portrays a more fluctuating trend for MRNA in 2025. The year is expected to start at $102.079, with the stock experiencing several periods of growth and decline. A notable peak is predicted in July-August, with the stock reaching $107.239, but then a decline is expected.

Moderna Stock Forecast for 2026

Let’s take a look at expert forecasts for the MRNA rate in 2026.

WalletInvestor

Price range for 2026: $61.045 – $ 85.294 (as of May 17, 2024).

According to WalletInvestor, Moderna’s stock price is projected to experience moderate fluctuations. A slight decline of 7% is expected in January. A series of ups and downs is projected from March to November, with a peak at 11.5% in August. However, the rate is expected to decline in the future, with a strong fall in October.

LongForecast

Price range for 2026: $222 – $464 (as of May 17, 2024).

According to LongForecast, Moderna’s stock in 2026 is expected to see a year of volatility. Starting strong in January, the stock will experience ups and downs in the first six months. Peak growth is forecasted in August-September and then — in December.

Long-Term Moderna Stock Forecast for 2027-2030

Moderna stock’s bullish trend is projected to continue from 2027 to 2030 as the company’s shares look promising. Walletinvestor’s projections, extending to 2028, indicate a significant upward trajectory, with the rate potentially increasing to $179.445 by late 2028.

This optimistic outlook for 2027-2030 is likely driven by Moderna’s pioneering work in mRNA technology and its expanding portfolio in pharmaceuticals and biotech. The company’s innovation in developing treatments and vaccines, especially in the rapidly evolving healthcare sector, positions it well for sustained growth and stability. Given these factors, the stock is expected to maintain an upward trend through 2030.

Recent Price History of the MRNA Stock

Moderna’s stock price history from January 2019 to December 2022 illustrates a remarkable journey of volatility and growth, reflecting the biotechnology sector’s dynamism. Starting at $16.60 in January 2019, the stock experienced gradual increments, closing at $20.35 in March 2019.

The pivotal moment came in 2020, amidst the global health crisis, when Moderna’s role in vaccine development catapulted its stock from $25.93 in February to an astounding $173.16 by January 2021, marking an unprecedented surge. However, this peak was followed by fluctuations, with the stock reaching its zenith at $497.49 in July 2021. Since then, a downward trend ensued, culminating in a December 2022 close of $179.62.

In 2023, we saw a rapid decline in MRNA’s share price. Starting the year at $204.1 in January, the stock dropped to a local minimum of $65.27 by November. Since then, the price has gradually risen: a bullish trend has begun.

Which Factors Impact Moderna Communications Inc.?

• Earnings Estimate Revisions: Moderna’s stock price is influenced by changes in analysts’ earnings estimates, reflecting the latest business trends. If these estimates increase, it implies a higher future value for the stock, attracting investor interest and potentially driving the price up.
• Projected Revenue Growth: Revenue forecasts are crucial, as they indicate the company’s growth potential. A significant change in projected revenues, either a decrease or an increase, can signal changes in the company’s financial health and affect its stock price.
• Last Reported Results and Surprise History: Moderna’s stock has been significantly impacted by its financial performance in recent quarters if the actual earnings and revenues differ from analysts’ expectations. Surpassing or missing these estimates can lead to adjustments in the stock’s perceived value and investor sentiment.
• Valuation: The valuation of Moderna’s stock is assessed using metrics like P/E, P/S, and P/CF ratios. Comparing these values to historical averages and industry peers helps determine if the stock is overvalued, undervalued, or reasonably priced, influencing investment decisions.
• Zacks Rank: This rank is based on earnings estimate revisions and other factors, indicating the stock’s potential performance. For instance, a Zacks Rank of #3 for Moderna suggests that the stock might soon perform on par with the broader market.

Conclusion: Is It Worth Investing in Moderna?

Moderna’s stock (MRNA) presents a fascinating future investment prospect, especially from 2024 to 2025. LongForecast’s projections suggest an upward trend, but WalletInvestor forecasts potential price fluctuations.

Moderna’s shares offer a compelling opportunity for those with a long-term investment perspective and a tolerance for market risks. The company’s strong position in the healthcare landscape underscores its potential as a profitable investment.

Price chart of MRNA in real time mode